The Access to COVID-19 Tools (ACT) Accelerator is the world’s most comprehensive end-to-end solution to ending the acute phase of the devastating COVID-19 pandemic. It brings together governments, health organizations, scientists, businesses, civil society, and philanthropists to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
The ACT Accelerator is a framework for collaboration. It is not a decision-making body or a new organization. It was set up in response to a call from G20 Leaders in March 2020 and launched by the WHO, European Commission, France and The Bill & Melinda Gates Foundation in April 2020.
The goal of the ACT Accelerator is to end the COVID-19 pandemic as quickly as possible by reducing COVID-19 mortality and severe disease through the accelerated development, equitable allocation, and scaled-up delivery of vaccines, therapeutics and diagnostics to reduce mortality and severe disease. This will accelerate the end of the health and economic crisis, restoring full societal and economic activity globally in the near term and facilitating high-level control of COVID-19 disease in the medium term.
The participating global health organizations are: the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), Unitaid, the Foundation for Innovative New Diagnostics (FIND), the Wellcome Trust, the World Bank Group and the Bill & Melinda Gates Foundation.
The ACT Accelerator is co-convened by nine leading global health organizations. It is not a new legal or decision-making entity but has been set up as a support structure to enable the work of the delivery partners and facilitate cross-cutting knowledge sharing.
The ACT Accelerator comprises four pillars: Diagnostics, Therapeutics and Vaccines (also known as COVAX), with the Health Systems Connector pillar working across the other three. Each pillar is managed by 2-3 partner agencies. Additionally, WHO leads on the cross-cutting Access and Allocation workstream.
The co-convenors of each pillar are fully accountable for making the investment case for that area. Grant management and financial reporting to donors is managed by the receiving entity. Formal governance for the pillars is provided by the Boards and governing bodies of the co-convened delivery partners.
WHO also hosts a support structure known as the ACT Accelerator Hub. The Hub ensures knowledge sharing across the pillars of the ACT Accelerator. It will consolidate a report on a regular basis against the work plans and the overall objectives.
The ACT Accelerator also has a Facilitation Council, whose primary function is to provide high-level advice and guidance to ACT Accelerator pillars, principals and partners, as well as global leadership and advocacy for the initiative.
A key principle underpinning the ACT Accelerator is the need for equitable distribution of COVID-19 tools to those most who need them most, as upheld through the Access and Allocation workstream. The fair allocation mechanism for COVID-19 vaccines through the COVAX Facility is based on the idea that whether a person can access tests, treatment and a vaccine for COVID-19 should not be determined by where they live. Read our Q&A on vaccine access and allocation for more information.
You can follow the status of COVID-19 Vaccines within WHO EUL/PQ evaluation process here.
As of November 19 2020, since the launch of the ACT Accelerator, the Diagnostics, Therapeutics, Vaccine the Health Systems Connector pillars have delivered the following:
Published on 24 September 2020, the ACT Accelerator Status Report and Plan outlines the aspiration, achievements to date, and plan for the ACT Accelerator. It is complemented by two Investment Case documents, which provide an economic rationale for investing in the ACT Accelerator:
The ACT Accelerator Facilitation Council was formally launched during a virtual meeting of its Members on 10 September 2020, where they issued a statement on the ACT Accelerator. The second meeting held to review the initiative’s progress took place on 3 November 2020.
Its primary functions are to provide high-level advice and guidance to ACT Accelerator pillars, principals and partners, as well as global leadership and advocacy for the initiative. The Council has been carefully composed to ensure an appropriate and diverse representation of global leaders and partners, and includes ACT Accelerator members and donors, market shapers and regional cooperation groups. It is co-chaired by Norway and South Africa and hosted by the European Commission and WHO.
A full breakdown of its membership can be found in the official ACT Accelerator Facilitation Council Terms of Reference.
The ACT Accelerator Commitment Tracker is a tool to transparently report on financial commitments to pillars and agencies of the ACT Accelerator. It tracks commitments to ACT Accelerator co-conveners that are applied against ACT Accelerator Pillar budgets (as presented in the ACT Accelerator’s Urgent Priorities & Financing Requirements, dated 10 November 2020).
The COVID-19 Health Funding tracker from the Economist Intelligence Unit (EIU) reports on COVID-19 response and research commitments more broadly and well beyond the scope of the ACT Accelerator, e.g. to WHO’s Strategic Preparedness and Response Plan, national institutes, the Drugs for Neglected Diseases initiative (DNDi), Global Antibiotic Research and Development Partnership (GARDP) and other multilaterals.
Please refer to the ACT Accelerator Commitment Tracker for the most up-to-date information.
Visit our 'How to contribute to the ACT Accelerator' page for more information.